RNAC icon

Cartesian Therapeutics
RNAC

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$37
446% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Mitchell Kapoor
0% 1-yr RNAC win rate
19 Nov ‘25 13 days ago
BTIG
BTIG
Julian Harrison
0% 1-yr RNAC win rate
14 Nov ‘25 18 days ago